Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
14
×
clinical trials
14
×
life sciences
national blog main
boston blog main
boston top stories
fda
national top stories
boston
san francisco blog main
deals
investing
new york blog main
san diego blog main
cancer
san diego top stories
startups
detroit blog main
detroit top stories
san francisco top stories
boulder/denver blog main
boulder/denver top stories
decibel therapeutics
europe blog main
gene therapy
indiana blog main
indiana top stories
ipo
national
new york top stories
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
atlas venture
biofourmis
What
therapeutics
14
×
medicines
drug
ipo
million
new
raised
treat
ago
approved
companies
company
developing
fda
biotech
biotechs
black
clinic
data
debut
diamond
disease
dyne
focus
genetic
hearing
late
leading
life
loss
muscle
public
rare
regenerative
science
targets
therapy
topped
week
years
Language
unset
Current search:
biotech
×
therapeutics
×
" clinical trials "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M